WilBio's Cell Engineering Conference was a great venue for InVitria to learn about the cell line development challenges facing the biopharmaceutical industry
Fort Collins, CO (PRWEB) January 5, 2009
The 2008 Cell Engineering Conference, hosted by the Williamsburg BioProcessing Foundation, featured the products and supporting research data of InVitria, a company committed to delivering affordable, high-performing cell culture media components for bioproduction and regenerative medicine applications.
Over the course of the three day conference in Santa Barbara, CA, InVitria exhibited its Cellastim and Lacromin cell culture media component products to industry leaders seeking ways to improve their development timelines and optimize bioproduction.
InVitria's Director of Cell Culture, Dr. Steve Pettit, presented at the meeting and revealed data from a study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO." Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in improved doubling time and an average 50% increase in productivity across a variety of chemically defined cell culture media.
"WilBio's Cell Engineering Conference was a great venue for InVitria to learn about the cell line development challenges facing the biopharmaceutical industry," said InVitria President Scott Deeter. "InVitria is dedicated to working with customers to improve cell line development speed by improving doubling time and expediting the development process without the use of serum or other animal components," Deeter said.
InVitria's Cellastim and Lacromin are animal free components used to enhance cell growth, reduce doubling times and optimize productivity in cell culture media. Cellastim and Lacromin are well-defined media components that improve performance for research, development and bioproduction.
For more information about InVitria's products, please contact us by e-mail or phone.